Search results
CMS approves codes for Invivyd's COVID-19 prophylaxis drug By Investing.com
Investing.com· 1 week agoThe Q code (Q0224) and M code (M0224) will be used for product reimbursement and administration...
CDC Expands Guidance on Informed Consent to Support Workplace SARS-CoV-2 Testing
The National Law Review· 1 week agoAs employers continue to grapple with a safe return to the workplace, the U.S. Centers for Disease Control and Prevention (CDC) issued new guidance for businesses and employers on SARS ...
Invivyd Announces CEO Transition - Invivyd (NASDAQ:IVVD)
Benzinga· 2 weeks agoInvivyd, Inc. IVVD, a biopharmaceutical company on a mission to protect the vulnerable from serious viral infectious diseases, today announced that the company's Board of Directors has appointed ...
Remdesivir tied to 25% lower risk of in-hospital death in adults with COVID and no added oxygen
Center for Infectious Disease Research and Policy· 1 week agoPrior studies based on early-pandemic data The study period, December 2020 to April 2022, spanned...
How Vir found the one: CEO Marianne De Backer
FierceBiotech· 6 days agoVir Biotechnology conducted a worldwide search to find the perfect CEO. In the end, the board picked Bayer’s Marianne De Backer, Ph.D., because of her...
Revive Therapeutics Announces FDA Acceptance of Meeting Request for Long COVID Diagnostic Product
Morningstar· 1 week agoTORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT: 31R), a specialty life sciences company focused on the research and development of therapeutics and diagnostics for
Scout Nabs $1M CARB-X Award for Point-of-Care Molecular STI Test
GenomeWeb News· 1 week agoDiagnostics developer Scout announced Thursday that it has been awarded $1 million in funding from the Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X). The funding ...
COVID-19 and PREP Act Immunity
The National Law Review· 1 week agoIn the wake of rising COVID-19 infections, many private companies have donated goods and services, developed testing and diagnostic tests, provided COVID-19 testing support to state and federal ...
